Business and people highlights from our June issue, including four recent hires and a new facility in the UK.
James Dixon
Bringing with him more than 25 years in the pharmaceutical, biotechnology, and CRO industries, James Dixon has been named Senior Vice President, Quality and Compliance at Cetero Research (Cary, NC).
Richard Farris
Novella Clinical (Research Triangle Park, NC) has made several changes to its team including the appointment of Richard Farris as Senior Director for Project Management and the promotion of Michael Doyle to Global Head of Regulatory Affairs.
Robin Sutherland
Quanticate (Cambridge, MA) has appointed Robin Sutherland as Head of US Operations where she will be responsible for all aspects of business expansion across the United States and Canada.
Dawn Duggan
Dawn Duggan has joined A10 Clinical Solutions (Cary, NC) as Director of Strategic Clinical Solutions where she will be responsible for strategically growing A10’s presence within the northeastern US pharmaceutical and biotechnology hub.
Dr. Reddy’s Laboratories
Pictured above: Y. Hamied, PhD, Chairman of Cipla and Honorary Fellow of Christ’s College, Cambridge, and G. V. Prasad, Vice Chairman and CEO.
Dr. Reddy’s Laboratories has opened a newly expanded Chirotech Technology Center at Cambridge Science Park, UK where Chirotech has been based for the last 20 years. The new 33,000 sq ft facility is purpose built for laboratories and offices and has been fitted to Dr. Reddy’s specific requirements for chemistry, biology and analytics.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Fast Tracks Johnson & Johnson’s Nipocalimab for Fetal Neonatal Alloimmune Thrombocytopenia
March 27th 2024Johnson & Johnson is moving forward with a pair of Phase III trials of nipocalimab to reduce the risk of fetal neonatal alloimmune thrombocytopenia in alloimmunized pregnant patients.